Vanguard Group »

Bridgebio Oncology Therapeut shares owned by Vanguard Group

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Vanguard Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.9M 791k 12.52
2025-09-30 $7.5M 648k 11.58

More positions owned by Vanguard Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)

View all positions for Vanguard Group

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut